Table 4.
Treatment and recurrence (no. of patients, n (%))
| Diffuse | Nodular | Necrotizing | Posterior | |
|---|---|---|---|---|
| Number of patients | 75 (62.5) | 25 (20.8) | 7 (5.8) | 13 (10.8) |
| Topical steroids | 71 (94.7) | 25 (100) | 6 (85.7) | 12 (92.3) |
| Oral NSAID | 40 (53.3) | 16 (64.0) | 3 (42.9) | 4 (30.8) |
| Oral corticosteroids | 37 (49.3) | 9 (36.0) | 6 (85.7) | 12 (92.3) |
| Oral immunosuppressives (excluding prednisolone) | 19 (25.3) | 3 (12.0) | 5 (71.4) | 5 (38.5) |
| Oral steroid or immunosuppressives | 40 (53.3) | 9 (36.0) | 6 (85.7) | 12 (92.3) |
| Recurrence | 14 (18.7) | 2 (8.0) | 2 (28.6) | 2 (15.4) |